BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 6142849)

  • 21. New horizons in the pharmacologic management of peptic ulceration.
    Debas HT; Mulholland MW
    Am J Surg; 1986 Mar; 151(3):422-30. PubMed ID: 2869709
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ranitidine and cimetidine for duodenal ulcer.
    Langman MJ; Henry DA; Ogilvie A
    Scand J Gastroenterol Suppl; 1981 Jun; 69():115-7. PubMed ID: 6119774
    [No Abstract]   [Full Text] [Related]  

  • 23. [Anomalies in gastric stump emptying of patients who have undergone resections for duodenal ulcer previously treated with histamine H2 receptor antagonists].
    Quaranta L; Segre D; Abbo L; Balestrino E; Clerico D; Emmolo I; Cardona R; Massimino S
    Minerva Chir; 1989 May; 44(10):1475-8. PubMed ID: 2570381
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Medical management of peptic ulcer.
    Misiewicz JJ
    Postgrad Med J; 1984 Nov; 60(709):751-9. PubMed ID: 6095240
    [No Abstract]   [Full Text] [Related]  

  • 25. Omeprazole and H2-receptor antagonists in the acute treatment of duodenal ulcer, gastric ulcer and reflux oesophagitis: a meta-analysis.
    Eriksson S; Långström G; Rikner L; Carlsson R; Naesdal J
    Eur J Gastroenterol Hepatol; 1995 May; 7(5):467-75. PubMed ID: 7614110
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Duodenal ulcer - conservative treatment, success and limitations].
    Demling L; Lux G
    Chirurg; 1982 Jan; 53(1):1-8. PubMed ID: 6120799
    [No Abstract]   [Full Text] [Related]  

  • 27. [Current aspects of the therapy of gastroduodenal peptic ulcer].
    Castro Lde P
    Rev Hosp Clin Fac Med Sao Paulo; 1983; 38(2):90-102. PubMed ID: 6139870
    [No Abstract]   [Full Text] [Related]  

  • 28. Can optimal acid suppression prevent rebleeding in peptic ulcer patients with a non-bleeding visible vessel: a preliminary report of a randomized comparative study.
    Lin HJ; Lo WC; Perng CL; Wang K; Lee FY
    Hepatogastroenterology; 1997; 44(17):1495-9. PubMed ID: 9356879
    [TBL] [Abstract][Full Text] [Related]  

  • 29. H2-receptor antagonists an Helicobacter pylori eradication.
    Lamers CB
    Scand J Gastroenterol Suppl; 1995; 212():126-7. PubMed ID: 8578225
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical evaluation of the effect of omeprazole, cimetidine, famotidine and ranitidine on histamine induced cutaneous wheal and flare response.
    Saha N; Sachdev A; Bhasin DK; Sankaranahyanan A; Khosla PP; Singh K; Sharma PL
    Int J Clin Pharmacol Ther Toxicol; 1993 Jul; 31(7):322-5. PubMed ID: 8103763
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The drug treatment of duodenal ulcer: physiological considerations in the choice of therapy.
    Jones DB; Hunt RH
    Aust N Z J Med; 1986 Apr; 16(2):263-7. PubMed ID: 2875708
    [No Abstract]   [Full Text] [Related]  

  • 32. The effect of ranitidine on gastric mucus, pepsin and hydrochloric acid secretion in patients with duodenal ulcer.
    Gabryelewicz A; Sarosiek J; Laszewicz W
    Acta Med Pol; 1981; 22(4):335-9. PubMed ID: 6128866
    [No Abstract]   [Full Text] [Related]  

  • 33. Control of gastric acid with high dose H2-receptor antagonists after omeprazole failure: report of two cases.
    Leite LP; Just RJ; Castell DO; Lagerström PO
    Am J Gastroenterol; 1995 Oct; 90(10):1874-7. PubMed ID: 7572913
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The effect of histamine H2 receptor blockaders on the proteolytic activity in patients with ulcers].
    Bashir BM
    Lab Delo; 1990; (4):25-7. PubMed ID: 1695268
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Therapy of resistant duodenal ulcer].
    Vigneri S; Scialabba A; Pisciotta G; Termini R; Muratore F; Vinti M
    Minerva Med; 1989 Nov; 80(11):1205-10. PubMed ID: 2574838
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [H2 receptor antagonists: clinical use].
    Archambault A
    Union Med Can; 1984 Dec; 113(12):990-1, 995-8, 1023. PubMed ID: 6151278
    [No Abstract]   [Full Text] [Related]  

  • 37. [Josamycin combination with ranitidine in therapy of gastroduodenal ulcer: clinical efficiency].
    Maev IV; Vertkin AL; Vovk EI; Masharova AA; Bezborodnyĭ SD; Lebedeva EG
    Klin Med (Mosk); 2000; 78(3):46-50. PubMed ID: 10790966
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Indications and results of surgical treatment of ulcers. Considerations after the introduction of H2-receptor antagonists].
    Barner S; Waldmann D; Farthmann EH
    Fortschr Med; 1984 Jul; 102(25-26):692-6. PubMed ID: 6147305
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Conservative treatment of the sick stomach and duodenal ulcers].
    Lotfi M
    ZFA (Stuttgart); 1981 Mar; 57(9):681-4. PubMed ID: 6112831
    [No Abstract]   [Full Text] [Related]  

  • 40. Meta-analysis of randomized clinical trials comparing lansoprazole with ranitidine or famotidine in the treatment of acute duodenal ulcer.
    Poynard T; Lemaire M; Agostini H
    Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):661-5. PubMed ID: 8590162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.